Dark Forest Capital Management LP Karuna Therapeutics, Inc. Transaction History

Dark Forest Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$176.32 - $240.22 $312,086 - $425,189	1,770 New	1,770 $383,000
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $20,425 - $45,774	165 New	165 $37,000
Q1 2022 May 13, 2022	SELL	$98.9 - $132.37 $94,350 - $126,280	-954 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$110.64 - $159.4 $19,030 - $27,416	172 Added 21.99%	954 $125,000
Q3 2021 Nov 12, 2021	BUY	$101.2 - $125.87 $7,286 - $9,062	72 Added 10.14%	782 $96,000
Q2 2021 Aug 16, 2021	BUY	$107.45 - $135.95 $76,289 - $96,524	710 New	710 $81,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.